是否应该为更多患者提供大麻素治疗？

Should more patients be offered treatment with cannabinoids?

作者信息

Teigen Ingrid Anna, Serkland Trond Trætteberg, Pahr Thomas, Berg Jon Andsnes

出版信息

Tidsskr Nor Laegeforen. 2019 Sep 23;139(13). doi: 10.4045/tidsskr.19.0211. Print 2019 Sep 24.

DOI:10.4045/tidsskr.19.0211

Abstract

Today, a small but growing number of patients in Norway are prescribed cannabinoids for medical use. Despite the large focus on their potential as medicines, there is limited scientific knowledge about the positive effects, adverse effects, long-term effects and interaction potential of cannabinoids.

摘要

如今，挪威有一小部分但数量在不断增加的患者被开具了用于医疗用途的大麻素。尽管人们高度关注大麻素作为药物的潜力，但关于其积极作用、副作用、长期影响和相互作用潜力的科学知识却很有限。